| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |